Importance Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell
lineage and include functioning tumors, characterized by the secretion of pituitary hormones …

Abstract The 13th Acromegaly Consensus Conference was held in November 2019 in Fort
Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and …

Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal
expansions of differentiated somatotroph cells and are usually sporadic. They are almost …

Guidelines and consensus statements ensure that physicians managing acromegaly
patients have access to current information on evidence-based treatments to optimize …

Abstract Purpose The 14th Acromegaly Consensus Conference was convened to consider
biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy …

Background COVID-19 has completely changed our daily clinical practice as well as our
social relations. Many organs and biological systems are involved in SARS-Cov-2 infection …

Background Despite COVID-19 being identified as severe respiratory viral infection,
progressively many relevant endocrine manifestations have been reported greatly …

Acromegaly is typically caused by a growth hormone–secreting pituitary adenoma, driving
excess secretion of insulin-like growth factor 1. Acromegaly may result in a variety of …

Abstract Purpose The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy
and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously …

Objective To date, no systematic reviews and meta-analysis on the global epidemiology of
acromegaly are available in the literature. The aims of this study are to provide a systematic …